ATLASINmune Bio (INMB) earnings date: Nov 5, 2026
INmune Bio (INMB) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$0.18.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on INMB
| Last price | $1.45 (-9.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.3% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the INmune Bio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
INmune Bio reports on Nov 5, 2026. One email the day before, with ATLAS’s read on INmune Bio. You can switch it off at any time.
Alert me before INMB reportsFree to start. Creating an account takes under a minute.
INMB earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.18 |
| Last report | Oct 29, 2026 |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -13.2% |
| Average move around a report | ±7.3% (last 4) |
| Sector | Healthcare · Biotechnology |
INmune Bio earnings history: last 5 reports
INmune Bio last reported on Oct 29, 2026: EPS of -$0.24 against an estimate of -$0.18.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | -$0.18 | -$0.24 | – | – | – |
| Aug 6, 2026 | -$0.20 | -$0.05 | +75.0% | Beat | +9.7% |
| Jul 9, 2026 | $0.04 | -$0.02 | -150.0% | Miss | +12.8% |
| May 7, 2026 | -$0.18 | -$0.20 | -11.1% | Miss | -5.9% |
| Mar 30, 2026 | -$0.27 | -$0.18 | +33.3% | Beat | +0.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for INMB
See the fair value, the probability range and the earnings history of INmune Bio on its ATLAS page.
INmune Bio (INMB) stock analysisPlans from €3.99 a month.
INmune Bio earnings: frequently asked questions
When does INmune Bio (INMB) report earnings?
INmune Bio is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for INMB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.18 per share (USD). Estimates can change before the report.
How often does INMB beat earnings estimates?
Of its last 4 reports with a recorded result, INmune Bio beat the EPS estimate 2 times; the average surprise was -13.2%. Past results do not predict the next one.
How much does INMB move around earnings?
Over its last 4 reports the stock moved an average of 7.3% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did INmune Bio beat earnings estimates last quarter?
INmune Bio last reported on Oct 29, 2026: EPS of -$0.24 against an estimate of -$0.18.
How much does INMB usually move in a day?
On a normal trading day the ATLAS model puts INMB’s one-day range at about ±4.3%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer